T. Rowe Price Associates
CMIIU

T. Rowe Price Associates’s CM Life Sciences II Inc. Unit CMIIU Stock Holding History

T. Rowe Price Associates’s Portfolio CMIIU Stock Details CMIIU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,658,794
Closed -$22.3M – 3021
2021
Q2 		$22.3M Sell
1,658,794
-44,506
-3% -$593K ﹤0.01% 1275
2021
Q1 		$21.8M Buy
+1,703,300
New +$21.4M ﹤0.01% 1258

T. Rowe Price Associates's CMIIU Position: Q3 2021 in Review

T. Rowe Price Associates sold out of CM Life Sciences II Inc. Unit (CMIIU) in Q3 2021, closing a stake of 1,658,794 shares — an estimated $22.3M sold.

T. Rowe Price Associates first reported a position in CMIIU in Q1 2021 and held it in 2 quarters. The position peaked at $22.3M in Q2 2021. 0 funds tracked by Wall St. Rank hold CMIIU as of Q3 2021.

  • T. Rowe Price Associates reported no remaining CM Life Sciences II Inc. Unit position as of Q3 2021 after selling out during the quarter.
  • T. Rowe Price Associates sold 1,658,794 CM Life Sciences II Inc. Unit shares in Q3 2021, an estimated $22.3M.
  • T. Rowe Price Associates first reported a position in CM Life Sciences II Inc. Unit in Q1 2021 and held it in 2 quarters.
  • T. Rowe Price Associates's CM Life Sciences II Inc. Unit position peaked at $22.3M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held CM Life Sciences II Inc. Unit as of Q3 2021.

Based on T. Rowe Price Associates's 13F filing for Q3 2021, filed 15 Nov 2021.